SBC Medical Group Holdings Inc (SBC): who owns it and who trades it
As of Nov 16, 2026, SBC insiders reported 3 open-market sales worth $20.1M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Yoshiyuki Aikawa (CEO), with $20.1M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling SBC Medical Group
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns SBC
57 funds and institutions reported SBC shares worth $13.7M at the end of Q2 2026, about 4% of the company. The largest holder is Lumbard & Kellner, LLC with 1.7%.
Funds and institutions (13F) 4%Everyone else 96%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Lumbard & Kellner, LLC | 1.73M | 1.68% | $5.3M | – |
| BlackRock, Inc. | 924,002 | 0.90% | $2.8M | – |
| Geode Capital Management, LLC | 427,864 | 0.42% | $1.3M | – |
| Citadel Advisors LLC | 144,718 | 0.14% | $446K | – |
| Vanguard Capital Management LLC | 135,783 | 0.13% | $418K | – |
| Northern Trust Corp | 131,204 | 0.13% | $404K | – |
| Vanguard Portfolio Management LLC | 128,295 | 0.13% | $395K | – |
| Hillsdale Investment Management Inc. | 124,800 | 0.12% | $384K | – |
| Segall Bryant & Hamill, LLC | 81,307 | 0.08% | $250K | – |
| Vanguard Fiduciary Trust Co | 66,281 | 0.06% | $204K | – |
| SBI Securities Co., Ltd. | 49,437 | 0.05% | $152K | – |
| State Street Corp | 49,239 | 0.05% | $152K | – |
| Charles Schwab Investment Management Inc | 46,855 | 0.05% | $144K | – |
| Sixth Street Partners Management Company, L.P. | 46,855 | 0.05% | $144K | – |
| Mariner, LLC | 33,747 | 0.03% | $104K | – |
| Bank of New York Mellon Corp | 26,991 | 0.03% | $83.1K | – |
| Nuveen, LLC | 25,381 | 0.02% | $78.2K | – |
| AQR Capital Management LLC | 24,098 | 0.02% | $74.2K | – |
| Central Pacific Bank - Trust Division | 24,000 | 0.02% | $73.9K | – |
| Two Sigma Securities, LLC | 21,487 | 0.02% | $66.2K | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, SBC insiders reported $0 of open-market purchases and $20.1M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Yoshiyuki Aikawa | CEO | Sale | 465,000 | $3.02 | $1.4M | Form 4 |
| Apr 21, 2026 | Yoshiyuki Aikawa | CEO | Sale | 3.10M | $3.02 | $9.4M | Form 4 |
| Mar 6, 2026 | Yoshiyuki Aikawa | CEO | Sale | 4.42M | $2.12 | $9.4M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Yoshiyuki Aikawa | Chairman and CEO, Director, 10% owner | – | $20.1M | Apr 28, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SBC short interest
Low short interest. 0.8% of SBC shares are sold short: about 1 share in 122. Over the last 12 reports the number of shares short went up 207%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 840,714 SBC shares were sold short, 0.8% of the shares outstanding, up 12.0% from the report before. At the average daily volume of 184,147 shares, buying them all back would take about 4.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 840,714 | 0.82% | +12% | 184,147 | 4.6 |
| Oct 15, 2026 | 750,813 | 0.73% | -8% | 192,228 | 3.9 |
| Sep 30, 2026 | 813,900 | 0.79% | +13% | 241,834 | 3.4 |
| Sep 15, 2026 | 717,532 | 0.70% | +3% | 176,871 | 4.1 |
| Aug 31, 2026 | 696,167 | 0.68% | +3% | 203,197 | 3.4 |
| Aug 14, 2026 | 674,547 | 0.66% | -17% | 144,961 | 4.7 |
| Jul 31, 2026 | 814,023 | 0.79% | -11% | 67,098 | 12.1 |
| Jul 15, 2026 | 914,813 | 0.89% | +67% | 93,798 | 9.8 |
| Jun 30, 2026 | 549,171 | 0.54% | +45% | 203,860 | 2.7 |
| Jun 15, 2026 | 377,572 | 0.37% | -3% | 103,770 | 3.6 |
| May 29, 2026 | 388,650 | 0.38% | +42% | 137,490 | 2.8 |
| May 15, 2026 | 273,445 | 0.27% | -12% | 129,472 | 2.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
SBC Medical Group company events
SBC Medical Group filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Aug 13, 2026.
- Aug 13, 2026ResultsReleased financial results. Filing
- Jul 14, 2026ListingThe date of the 2026 Annual Meeting of Stockholders of SBC Medical Group Holdings Incorporated, the Company notified the Listing Qualifications Department of the Nasdaq Stock Market LLC, that as of the Annual Meeting, the Company would cease to be in compliance with the Nasdaq independence rules… Filing
- May 20, 2026LeadershipMike Sayama, an independent director of SBC Medical Group Holdings Incorporated, notified the Company that he would not seek re-election at the Company’s forthcoming 2026 Annual Meeting of Stockholders. Filing
- May 14, 2026ResultsReleased financial results. Filing
- Apr 23, 2026AgreementSBC Medical Group Holdings Incorporated entered into an underwriting agreement by and among the Company, Dr. Yoshiyuki Aikawa, the Company’s CEO and Chairman of the board of directors, as selling stockholder and Maxim Group LLC, as representative of the several underwriters named in Schedule 1… Filing
- Mar 27, 2026AnnouncementIn connection with the Company’s announcements described in this Current Report on Form 8-K, the Company announced certain updates to its business strategy and capital policy, as summarized in Exhibit 99.2 hereto, which is incorporated herein by reference. Filing
- Jan 5, 2026AnnouncementOf this Current Report on Form 8-K. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Filing
- Dec 31, 2025AnnouncementOf this Current Report on Form 8-K. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Filing
- Dec 15, 2025AnnouncementSBC Medical Group Holdings Incorporated issued a press release announcing that the final results of the tender offer conducted by SBC Medical Group Co., Ltd. for shares of the common stock of Waqoo, Inc., a Japanese corporation listed on the Tokyo Stock Exchange Growth Market. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
SBC Medical Group financials
Famous investors that hold SBC
2 of the 50 well-known investors we track reported holding SBC in their latest 13F filing. The largest position is Ken Griffin's, worth $300K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 60,723 | $300K | 0.0% | -58% |
| Israel Englander · Millennium Management | Q3 2026 | 13,436 | $66.4K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about SBC Medical Group Holdings Inc (SBC) stock
Who owns the most SBC stock?
The largest reported owner of SBC Medical Group Holdings Inc (SBC) is Lumbard & Kellner, LLC, with 1.7% of the company. In total, 57 funds and institutions reported holding SBC at the end of Q2 2026, together about 4% of the shares. See the largest owners.
Are SBC insiders buying or selling?
In the last 12 months, SBC insiders reported no open-market purchases and 3 sales worth $20.1M. The latest trade was on Apr 28, 2026. See every trade.
What is the short interest in SBC?
As of Oct 30, 2026, 840,714 SBC shares were sold short, 0.8% of the shares outstanding, up 12.0% from the report before. At the average daily volume of 184,147 shares, buying them all back would take about 4.6 trading days (days to cover). See the history.
Which famous investors hold SBC?
2 of the 50 well-known investors we track reported SBC in their latest 13F filing, including Ken Griffin, Israel Englander. The largest position is worth $300K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.